Skip to content

Startup & venture capital news

Biomatter raises USD 18m Series A for AI enzyme design

Astanor led the financing for the Lithuanian biotechnology company.

By /

LinkedInX
Biomatter: Biomatter raises USD 18m Series A for AI enzyme design

Biomatter raised USD 18 million in a Series A led by Astanor. The Vilnius company uses artificial intelligence and experimental biology to design enzymes for industrial customers. It says the capital will support international expansion, additional laboratory capacity and further development of its design platform. Technical performance and customer impact claims remain company reported. The amount, round, location and lead investor were confirmed through the company announcement and independent reporting by TNW. The financing is recorded in the currency used by the company announcement.

Keep reading

More Funding

All stories